摘要
目的探讨米非司酮用于卵巢子宫内膜异位症腹腔镜术后的疗效。方法选择因卵巢子宫内膜异位症在苏大一附院行腹腔镜术的患者86例,随机分为2组,A组为米非司酮治疗组(56例);B组为单纯腹腔镜手术组(30例)。所有患者随访24个月,观察疗效。结果米非司酮组有效率为80.36%;单纯手术组有效率为56.67%。服药组疗效明显优于单纯手术组(P<0.05)。结论米非司酮用于卵巢子宫内膜异位症腹腔镜术后的治疗,有效、方便、廉价及副反应小,可作为术后药物治疗的选择。
Objective To investigate the role of mifepristone in ovary endometriosis after laparoscopic surgery. Methods Eightsix women with ovary endometriosis after Laparoscopic surgery were divided into two groups：group A -56 cases in mifepriston;group B -30 cases in laparoscopic surgery only. All patients were visited 24 months and observed curative effect. Results Rates of efficiency was 80.36% in group A. Rates of efficiency was 56.67% in group B. The effects of group A were significant higher than group B （ P 〈 0. 05 ）. Conclusions Depot mifepristone seems to be an effective and convenient treatment for ovary endometriosis with low - cost and few side effects. Then it can be used medication after surgery.
出处
《医学信息（手术学分册）》
2008年第11期1006-1007,共2页
Medical Information Operations Sciences Fascicule
